Medical-grade silicone induces release of proinflammatory cytokines in peripheral blood mononuclear cells without activating T cells

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 90 B, Issue 2, 2009, Pages 510-520

  Miro Mur, Francesc ^a,b   Hindié, Mathilde ^a,b   Kandhaya Pillai, Renuka ^a,b   Tobajas, Vanessa ^a,b   Schwartz Jr , Simo ^a,b   Alijotas Reig, Jaume ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Inflammation; Late adverse reactions; PBMC; Silicone dermal filler

Indexed keywords

ABERRATIONS; BLOOD; CELL CULTURE; CELL MEMBRANES; CHEMICAL ACTIVATION; FILLERS; PATHOLOGY;

ADVERSE EFFECT; DERMAL FILLERS; HEALTHY CONTROLS; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY RESPONSE; LATE ADVERSE REACTIONS; MEDIATED REACTIONS; MONOCYTE-DERIVED MACROPHAGES; PBMC; PERIPHERAL BLOOD MONONUCLEAR CELLS; PLASTIC SURGERY; POLYCLONAL; PROINFLAMMATORY CYTOKINES; T CELLS;

SILICONES;

CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SILICONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; SCLERODERMA; SILICONE PROSTHESIS; SKIN NODULE; T LYMPHOCYTE;

EID: 67749145818     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31312     Document Type: Article

References (38)

1. Alijotas-Reig J, García-Domingo M. Silicone and autoimmune diseases. An Med Interna 1998;15:276-283.
2. Alijotas-Reig J, Garcia-Gimenez V. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: Clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol 2008;22:150-161.
3. Alijotas-Reig J, Garcia-Gimenez V, Miró-Mur F, Vilardell- Tarrés M. Delayed immune-mediated adverse effects related to polyalkylimide dermal fillers: Clinical findings and longterm follow-up. Arch Dermatol 2008;144:637-642. (Pubitemid 351724424)
4. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007;33:S168-S175. (Pubitemid 350233456)
5. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005;29:34-48. (Pubitemid 40685159)
6. Requena C, Izquierdo M, Navarro M, Martínez A, Vilata J, Botella R, Amorrortu J, Sabater V, Aliaga A, Requena L. Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol 2001;23:197-202. (Pubitemid 32525408)
7. Asherson R, Shoenfeld Y, Jacobs P, Bosman C. An unusually complicated case of primary Sjögren's syndrome: Development of transient "lupus-type" autoantibodies following silicone implant rejection. J Rheumatol 2004;31:196-197.
8. Bar-Meir E, Eherenfeld M, Shoenfeld Y. Silicone gel breast implants and connective tissue disease-A comprehensive review. Autoimmunity 2003;36:193-197. (Pubitemid 36966191)
9. Angell M. Do breast implants cause systemic disease? Science in the courtroom. N Engl J Med 1994;330:1748-1749. (Pubitemid 24171035)
10. Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 1994;330: 1697-1702.
11. Sanchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 1995;332:1666-1670.
12. Sanchez-Guerrero J, Liang MH. Silicone breast implants and connective tissue diseases. BMJ 1994a;309:822-823. (Pubitemid 24305000)
13. Sanchez-Guerrero J, Schur PH, Sergent J, Liang MH. Silicone breast implants and rheumatic disease: Clinical, immunological, and epidemiological studies. Arthritis Rheum 1994b;37: 158-168. (Pubitemid 24065489)
14. Gaubitz M, Jackisch C, Domschke W, Heindel W, Pfleiderer B. Silicone breast implants: Correlation between implant ruptures, magnetic resonance spectroscopically estimated silicone presence in the liver, antibody status and clinical symptoms. Rheumatology 2002;41:129-135. (Pubitemid 34537887)
15. Karlson EW, Lee I, Cook N, Buring J, Hennekens C, Bloch K. Serologic evaluations of women exposed to breast implants. J Rheumatol 2001;28:1523-1530. (Pubitemid 32660623)
16. Karlson EW, Tanasijevic M, Hankinson S, Liang MH, Colditz G, Speizer F, Schur PH. Monoclonal gammopathy of undetermined significance and exposure to breast implants. Arch Intern Med 2001b;161:864-867. (Pubitemid 32225396)
17. Bar-Meir E, Teuber S, Lin H, Alosacie I, Goddard G, Terybery J, Barka N, Shen B, Peter J, Blank M, Gershwin ME, Shoenfeld Y. Multiple autoantibodies in patients with silicone breast implants. J Autoimmun 1995;8:267-277.
18. Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005;38: 235-245. (Pubitemid 40959897)
19. Karlson EW, Hankinson S, Liang M, Sanchez-Guerrero J, Colditz G, Rosenau B, Speizer F, Schur P. Association of silicone breast implants with immunologic abnormalities: A prospective study. Am J Med 1999;106:11-19. (Pubitemid 29077137)
20. Zandman-Goddard G, Blank M, Eherenfeld M, Gilburd B, Peter J, Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol 1999;26:73-77. (Pubitemid 29051398)
21. Vojdani A, Brautbar N, Campbell AW. Antibody to silicone and native macromolecules in women with silicone breast implants. Immunopharmacol Immunotoxicol 1994;16:497-523. (Pubitemid 24374825)
22. De Jong WH, Kallewaard M, Goldhoorn CA, Verhoef CM, Bijlsma JWJ, Schouten JSAG, Loveren HV. Long-term exposure to silicone breast implants does not induce antipolymer antibodies. Biomaterials 2004;25:1095-1103. (Pubitemid 37393299)
23. Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M, Nakano T, Fukuoka K, Kishimoto T, Hyodoh F, Ueki A, Nishimura Y. Immunological effects of silica and asbestos. Cell Mol Immunol 2007;4:261-268.
24. Ueki A, Yamaguchi M, Ueki H, Watanabe Y, Ohsawa G, kinugawa K, Kawakami Y, Hyodoh F. Polyclonal human Tcell activation by silicate in vitro. Immunology 1994;82:332-335.
25. Steen V, Powell D, Medsger TJ. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203. (Pubitemid 18088039)
26. Katzin WE, Feng LJ, Abbuhl M, Klein MA. Phenotype of lymphocytes associated with the inflammatory reaction to silicone gel breast implants. Clin Diagn Lab Immunol 1996;3: 156-161. (Pubitemid 26103751)
27. Wells A, Daniels S, Gunasekaran S, Wells K. Local increase in hyaluronic acid and interleukin-2 in the capsules surrounding silicone breast implants. Ann Plast Surg 1994;33:1-5. (Pubitemid 24208668)
28. Katzin W, Centeno J, Feng L, Kiley M, Mullick F. Pathology of lymph nodes from patients with breast implants: A histologic and spectroscopic evaluation. Am J Surg Pathol 2005; 29:506-511. (Pubitemid 40411184)
29. Christensen L, Breiting V, Vuust J, Hogdall E. Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): Causes and treatment. Eur J Plast Surg 2006;28:464-471. (Pubitemid 43337248)
30. Wu P, Hyodoh F, Hatayama T, Sakaguchi H, Hatada S, Miura Y, Takata-Tomokuni A, Katsuyama H, Otsuki T. Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A. Immunol Lett 2005;98:145-152. (Pubitemid 40409830)
31. Prantl L, Fichtner-Feigi S, Hofstaedter F, Lenich A, Eisenmann- Klein M, Schreml S. Flow cytometric analysis of peripheral blood lymphocyte subsets in patients with silicone breast implants. Plast Reconstr Surg 2008;121:25-30.
32. Vojdani A, Campbell A, Brautbar N. Immune functional abnormalities in patients with clinical abnormalities and silicone breast implants. Toxicol Ind Health 1992;8:415-429. (Pubitemid 23128809)
33. Granchi D, Ciapetti G, Savarino L, Stea S, Filippini F, Sudanese A, Rotini R, Giunti A. Expression of the CD69 activation antigen on lymphocytes of patients with hip prosthesis. Biomaterials 2000;21:2059-2065. (Pubitemid 30488076)
34. Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440:808-812.
35. Naim JO, Ippolito K, van Oss CJ. Adjuvancy effect of different types of silicone gel. J Biomed Mater Res 1997;37:534-538. (Pubitemid 27514861)
36. Naim JO, Satoh M, Buehner NA, Ippolito KML, Yoshida H, Nusz D, Kurtelawicz L, Cramer SF, Reeves WH. Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice. Clin Diagn Lab Immunol 2000;7:366-370. (Pubitemid 30263026)
37. Sporri R, Reis e Sousa C. Inflammatory mediators are insuffi- cient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 2005;6:163-170.
38. Tacke F, Ginhoux F, Jakubzick C, van Rooijen N, Merad M, Randolph GJ. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J Exp Med 2006;203:583-597.